findmyKOL

James Walsh, MD

Basic profile

Ophthalmology

ORCIDNone on fileNPI
RegionSaint Louis, MO · MidwestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH funding1999–2025Why? →

James Walsh is an Ophthalmology physician. ClinicalTrials.gov lists 8 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 1999–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

517 S Euclid Ave
Dept Opthalmology, 1st Fl
Saint Louis, MO 631101007

Telephone

314-362-3431

Provider last certified this registry record 7 Jun 2022.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    57.7%
    Corticosteroid20%
    Prednisolone Acetate100%
    Part D60 patients
    Prostaglandin Analog10.5%
    Latanoprost85%Tafluprost15%
    Part D<11 patients

    + 5 more classes in this area

  • Cancer & immunology

    22.9%
    Folate Analog Metabolic Inhibitor11.3%
    Methotrexate85%Methotrexate Sodium15%
    Part D<11 patients
    TNF inhibitor9%
    Humira(Cf) Pen74%Humira(Cf)26%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    15.6%
    Corticosteroid13.2%
    Prednisone100%
    Part D50 patients
    Antidiarrheal microorganisms2.4%
    Folic Acid100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 19992025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”